We want to make you aware that for Medicare Part D claims currently processing on the OptumRx claim adjudication system, you may see transitional benefit messaging returned, on both paid and rejected claims, which are not applicable to why claims have paid or rejected. This is most commonly occurring with claims that are reading Drug Utilization edits in place for the plan sponsors. The claims are paying and rejected appropriately. We are working to get the messaging updated to mitigate confusion. You should see this updated in March 2016.

On April 16, 2015 the Medicare Access and CHIP Authorization Act of 2015 (MACRA) was signed into law. Section 507 of MACRA amends Section 1860D-4(c) of the Social Security Act by requiring that pharmacy claims for covered Part D drugs include an active and valid Type 1 National Provider Identifier (NPI). Beginning January 1, 2016 a Part D sponsor cannot pay a claim that does not include an active and valid prescriber NPI. Effective January 1, 2016 pharmacies must submit claims with an active and valid prescriber NPI – the SCC 49 value will be discontinued. The legislation invalidates the use of Submission Clarification Code (SCC) value 49 "Prescriber does not currently have an Active Type 1 NPI.” Claims without the NPI will reject with reject code 34 - M/I Sbm Clarification Cde If you have questions, please call the OptumRx Help Desk anytime:  UnitedHealthcare Medicare Prescription Drug Plans : 877-889-6481  UnitedHealthcare Medicare Advantage Prescription Drug Plans: 877-889-6510  All other plans: Use Toll-Free-Number on Member’s ID Card Please distribute

OptumRx will assume responsibility for claims processing for members of Akima, LLC. Please Note:  All plan participants of Akima, LLC will receive a new member identification (ID) card.  Prescriptions need to be processed on-line using the Akima, LLC ID card information.

OptumRx will assume responsibility for claims processing for members of Ennis, Inc. Please Note:  All plan participants of Ennis, Inc. will receive a new member identification (ID) card.  Prescriptions need to be processed on-line using the Ennis, Inc. ID card information.

Dear Healthcare Professional: On December 21, 2015, Baxter announced a recall of one lot of dextrose 70% injection because of the presence of particulate matter in the solution of a single unit of the lot. Catamaran, an OptumRx company, notified members who may be affected by this recall. These members were provided information to help them identify if their medication is being recalled and advised not to use the recalled medication. In the future, these members may inquire about the dextrose injection solution prescription(s) you dispensed. If you have any questions, please call Baxter at 800-422-9837 (Monday through Friday, 8:00 am – 5:00 pm, CT) for more information about this recall. Sincerely, Catamaran, an OptumRx company